Deep vein thrombosis using noncontrast-enhanced MR venography with electrocardiographically gated three - Dimensional half-fourier FSE: Preliminary experience

Magnetic Resonance in Medicine

Volumn 61, Issue 4, 2009, Pages 907-917

  Ono, Atsushi ^a,b   Murase, Kenya ^a   Taniguchi, Toshitaka ^c   Shibutani, Osamu ^d   Takata, Satoru ^b   Kobashi, Yasuyuki ^b   Miyazaki, Mitsue ^e,f,g  

^a OSAKA UNIVERSITY   (Japan)

^b Kousei Hospital   (Japan)

^c KAWASAKI MEDICAL SCHOOL   (Japan)

^d Mitsubishi Mizushima Hospital   (Japan)

^e Toshiba Medical Research Institute USA   (United States)

^f TOSHIBA MEDICAL SYSTEMS CORPORATION   (Japan)

^g OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Deep vein thrombosis; Electrocardiography triggered three dimensional half fourier fse; Metallic implant; Noncontrast enhanced magnetic resonance venography

Indexed keywords

BLOOD; BLOOD VESSELS; DISEASES; FOURIER TRANSFORMS; IMAGE QUALITY; MAGNETIC RESONANCE;

COMPARATIVE STUDIES; DEEP VEIN THROMBOSIS; FOURIER; IMAGING SEQUENCE; MAGNETIC RESONANCE VENOGRAPHY; METALLIC IMPLANTS; SIGNAL TO NOISE; SUSCEPTIBILITY ARTIFACTS;

SIGNAL TO NOISE RATIO;

ARTICLE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTRAST ENHANCEMENT; DEEP VEIN THROMBOSIS; ELECTROCARDIOGRAPHY; FOURIER ANALYSIS; HUMAN; IMAGE QUALITY; METAL IMPLANTATION; NORMAL HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PHLEBOGRAPHY; QUANTITATIVE ANALYSIS; SIGNAL NOISE RATIO; THREE DIMENSIONAL IMAGING;

EID: 66249089450     PISSN: 07403194     EISSN: 15222594     Source Type: Journal    
DOI: 10.1002/mrm.21924     Document Type: Article

References (40)

1. Girard P. Sanchez O. Leroyer C. Musset D. Meyer G. Stern JB, Parent F; Evaluation du Scanner Spiralé dans l'Embolie Pulmonaire Study Group. Deep venous thrombosis in patients with acute pulmonary embolism: prevalence, risk factors, and clinical significance. Chest 2005;128:1593-1600.
2. Kakkar VV, Howe CT, Flanc C. Clarke, MB. Natural history of postoperative deep-vein thrombosis. Lancet 1969;2:230-232.
3. Bates SM, Ginsberg JS. Clinical practice. Treatment of deep-vein thrombosis. N Engl J Med 2004;351:268-277.
4. Anderson FA Jr, Spencer FA. Risk factors for venous thromboembolism. Circulation 2003;107:19-16.
5. Moody AR, Pollock JG, O'Connor AR, Bagnall M. Lower-limb deep venous thrombosis: direct MR imaging of the thrombus. Radiology 1998;209:349-355.
6. Fraser DG, Moody AR, Morgan PS, Martel AL, Davidson I. Diagnosis of lower-limb deep venous thrombosis: a prospective blinded study of magnetic resonance direct thrombus imaging. Ann Intern Med 2002; 136:89-98.
7. Aschauer M. Deutschmann HA, Stollberger R. Hausegger KA, Obernosterer A. Schöllnast H. Ebner F. Value of a blood pool contrast agent in MR venography of the lower extremities and pelvis: preliminary results in 12 patients. Magn Reson Med 2003;50:993-1002.
8. Erdman WA, Jayson HT, Redman HC, Miller GL, Parkey RW, Peshock RW. Deep venous thrombosis of extremities: role of MR imaging in the diagnosis. Radiology 1990;174:425-431.
9. Evans AJ, Sostman HD, Knelson MH, Spritzer CE, Newman GE, Paine SS, Beam CA. 1992 ARRS Executive Council Award. Detection of deep venous thrombosis: prospective comparison of MR imaging with contrast venography. AJR Am J Roentgenol 1993;161:131-139.
10. Dupas B, el Kouri D. Curtet C. Peltier P, de Faucal P. Planchon B. Lejeune JJ. Angiomagnetic resonance imaging of iliofemorocaval venous thrombosis. Lancet 1995;346:17-19.
11. Polak JF, Fox LA. MR assessment of the extremity veins. Semin Ultrasound CT MR 1999;20:36-46.
12. Lebowitz JA, Rofsky NM, Krinsky GA, Weinreb JC. Gadolinium-enhanced body MR venography with subtraction technique. AJR Am J Roentgenol 1997;169:755-758.
13. Li W. David V. Kaplan R. Edelman RR. Three-dimensional low dose gadolinium-enhanced peripheral MR venography. J Magn Reson Imaging 1998;8:630-633.
14. Sharafuddin MJ, Stolpen AH, Dang YM, Andresen KJ, Roh BS. Comparison of MS-325- and gadodiamide-enhanced MR venography of iliocaval veins. J Vasc Interv Radiol 2002;13:1021-1027.
15. Fraser DG, Moody AR, Davidson IR, Martel AL, Morgan PS. Deep venous thrombosis: diagnosis by using venous enhanced subtracted peak arterial MR venography versus conventional venography. Radiology 2003;226:812-820.
16. Larsson EM, Sundén P. Olsson CG, Debatin J. Duerinckx AJ, Baum R. Hahn D. Ebner F. MR venography using an intravascular contrast agent: results from a multicenter phase 2 study of dosage. AJR Am J Roentgenol 2003;180:227-232.
17. Li W. Salanitri J. Tutton S. Dunkle EE, Schneider JR, Caprini JA, Pierchala LN, Jacobs PM, Edelman RR. Lower extremity deep venous thrombosis: evaluation with ferumoxytol-enhanced MR imaging and dual-contrast mechanism - preliminary experience. Radiology 2007; 242:873-881.
18. Pedrosa I. Morrin M. Oleaga L. Baptista J. Rofsky NM. Is true FISP imaging reliable in the evaluation of venous thrombosis? AJR Am J Roentgenol 2005;185:1632-1640.
19. Cantwell CP, Cradock A. Bruzzi J. Fitzpatrick P. Eustace S. Murray JG. MR venography with true fast imaging with steady-state precession for suspected lower-limb deep vein thrombosis. J Vasc Interv Radiol 2006; 17:1763-1769.
20. Miyazaki M. Lee VS. Nonenhanced MR angiography. Radiology 2008; 248:20-43.
21. Shinde TS, Lee VS, Rofsky NM, Krinsky GA, Weinreb JC. Three-dimensional gadolinium-enhanced MR venographic evaluation of patency of central veins in the thorax: initial experience. Radiology 1999;213:555-560.
22. Li W. Tutton S. Vu AT, Pierchala L. Li BS, Lewis JM, Prasad PV, Edelman RR. First-pass contrast-enhanced magnetic resonance angiography in humans using ferumoxytol, a novel ultrasmall superparamagnetic iron oxide (USPIO)-based blood pool agent. J Magn Reson Imaging 2005;21:46-52.
23. Grobner T. Gadolinium - a specific trigger for the development of nephrogenic fibrosing dermopathy and nephrogenic systemic fibrosis? Nephrol Dial Transplant 2006;21:1104-1108.
24. Broome DR, Girguis MS, Baron PW, Cottrell AC, Kjellin I. Kirk GA. Gadodiamide-associated nephrogenic systemic fibrosis: why radiologists should be concerned. AJR Am J Roentgenol 2007;188:586-592.
25. Miyazaki M. Sugiura S. Tateishi F. Wada H. Kassai Y. Abe H. Noncontrast-enhanced MR angiography using 3D ECG-synchronized half Fourier fast spin echo. J Magn Reson Imaging 2000;12:776-783.
26. Urata J. Miyazaki M. Wada H. Nakaura T. Yamashita Y. Takahashi M. Clinical evaluation of aortic diseases using nonenhanced MRA with ECG-triggered 3D half-Fourier FSE. J Magn Reson Imaging 2001;14: 113-119.
27. Ono A. Miyazaki M. Takata S. Nakai M. Takeishi A. Kuriyama M. Kawakami Y. Taniguchi T. Shibutani O. Watanabe N. Ikeda M. Sanou K. Kobashi Y. Hayashi Y. Nagamachi T. Fujii H. Anami D. Evaluation of arterial occlusive diseases in lower extremity using non-contrastenhanced MR arteriography with ECG triggered 3D half-Fourier FSE: initial experience at 0.5T. In: Proc 11th Annual Meeting ISMRM, Toronto, 2003. p 1713.
28. Doi H. Ono A. Kawai A. Morimoto Y. Kunisada T. Nakata E. Ozaki T. Magnetic resonance angiography without contrast enhancement medium in bone and soft tissue tumors. Oncol Rep 2006;15:681-685.
29. Yokoyama K. Nitatori T. Inaoka S. Takahara T. Hachiya J. Non-contrast enhanced MR venography using 3D fresh blood imaging (FBI): initial experience. Radiat Med 2001;19:247-253.
30. Miyazaki M. Takai H. Sugiura S. Wada H. Kuwahara R. Urata J. Peripheral MR angiography: separation of arteries from veins with flowspoiled gradient pulses in electrocardiography-triggered three-dimensional half-Fourier fast spin-echo imaging. Radiology 2003;227:890-896.
31. Miyazaki M. Ichinose N. Sugiura S. Kassai Y. Kanazawa H. Machida Y. A, novel MR angiography technique: SPEED acquisition using half-Fourier RARE. J Magn Reson Imaging 1998;8:505-507.
32. Gallix BP, Achard-Lichère C. Dauzat M. Bruel JM, Lopez FM. Flowindependent magnetic resonance venography of the calf. J Magn Reson Imaging 2003;17:421-426.
33. Killewich LA, Sandager GP, Nguyen AH, Lilly MP, Flinn WR. Venous hemodynamics during impulse foot pumping. J Vasc Surg 1995;22: 598-605.
34. American Society for Testing and Materials (ASTM) International. F2182-02 test method for measurement of radio frequency induced heating near passive implants during magnetic resonance imaging. West Conshohocken, PA: American Society for Testing and Materials (ASTM) International; 2003.
35. Cho KH, Kim JS, Kwon SU, Cho AH, Kang DW. Significance of susceptibility vessel sign on T2-weighted gradient echo imaging for identification of stroke subtypes. Stroke 2005;36:2379-2383.
36. Gomori JM, Grossman RI, Goldberg HI, Zimmerman RA, Bilaniuk LT. Intracranial hematomas: imaging by high-field MR. Radiology 1985; 157:87-93.
37. Shellock FG. Radiofrequency energy-induced heating during MR procedures: a review. J Magn Reson Imaging 2000;12:30-36.
38. Muranaka H. Horiguchi T. Usui S. Ueda Y. Nakamura O. Ikeda F. Iwakura K. Nakaya G. Evaluation of RF heating on humerus implant in phantoms during 1.5T MR imaging and comparisons with electromagnetic simulation. Magn Reson Med Sci 2006;5:79-88.
39. Henning J. Weigel M. Scheffler K. Multiecho sequences with variable refocusing flip angles: optimization of signal behavior using smooth transitions between pseudo steady states (TRAPS). Magn Reson Med 2003;49:527-535.
40. Busse RF. Reduced RF power without blurring: correcting for modulation of refocusing flip angle in FSE sequences. Magn Reson Med 2004; 51:1031-1037.